Mr. Abed Elkeshk is the Senior Executive Vice President & Treasurer/Chief Financial Officer for the University of Mount Saint Vincent, located in New York City. Mr. Elkeshk has served over 16 years at the University and is a member of the President’s Cabinet, Treasurer for the Board of Trustees, and supports the Finance, Audit Committees, and the Investment Sub-Committee, all while providing leadership that shapes the University’s future, strategic initiatives, and its policies.

Mr. Elkeshk loves to extend his financial expertise, forward-thinking entrepreneurship, and collaborative leadership skills to many causes in need. He was the Chairman of the Board of trustees of EIHAB Human Services in New York and Pennsylvania for 12 years. Mr. Elkeshk is currently the Chairman of the Board of Trustees at the Egyptian American Community Foundation, Chairman of the New Egypt Group, Inc, and he is the founder of International Egyptian Women’s Club with members in the United States, England, and Egypt. Additionally, Mr. Elkeshk serves as a board member for the Egypt Cancer Network in the United States. This organization supports the largest free-standing pediatric cancer hospital in the world – The Children’s Cancer Hospital of Egypt.

M.D. FSCAI

American Board Certified and Fellowship Trained Interventional Cardiologist.

Dr Ahmed S. Ahmed, Clinical Assistant Professor in the Department of Medicine, Cardiology Division at the University of Texas Medical Health Science Center School of Medicine, Clinical Assistant Professor in the Department of Medicine at the University of Texas Medical Branch in Galveston, earned his Medical degree in Kar El-Einy Medical School, Cairo University where he graduated with honors, he completed his Internal Medicine Residency training in the University of Texas Medical Branch in Galveston and went on to join the Cardiology Fellowship program in the University of Missouri in Columbia.

Dr Ahmed subsequently pursued advanced training in the Cardiology Subspecialty of Interventional Cardiology  where he received specialized training in treating blocked arteries in the heart and legs with state of the art technology and devices.

Dr Ahmed is a Diplomat of four prestigious Board Certification including Cardiovascular disease, Interventional Cardiology, Nuclear Cardiology and Advanced Heart failure and Cardiac transplant.

Dr Ahmed has extensive and solid background in the Cardiovascular disease screening and management and in cooperation with the American College of Cardiology he published and presented in numerous esteemed Medical Journal and National Cardiology Conferences including the American College of Cardiology and the Transcatheter Cardiovascular Therapeutics conferences, he received several Excellency Awards to include “3rd Annual Cardiology Fellows Forum of Excellence Award” American Heart Association 2003 and “Young Investigator Award”. First Annual Cardiology Fellowship Conference, Cardiology 2004.

Dr Ahmed is especially interested in cardiovascular risk factors including hypertension, diabetes mellitus and high Cholesterol and their effects on the heart and the use of new devices and stents to treat heart arteries and peripheral vascular diseases.

M.D, PhD, FACS (President)

• Board Certified Plastic Surgeon
• Diplomate of the American Board of Plastic Surgery
• Assistant Clinical Professor UCI (WOS)
• Assistant Clinical Professor UCLA-H

Dr. Hisham Seify is a Board Certified Plastic Surgeon. He is a fellow of the American College of Surgeons, an active member of the American Society of Plastic Surgeons (ASPS) and The American Society of Aesthetic Plastic Surgeons (ASAPS).

Dr. Seify graduated from Cairo University with honors in 1992. He spent 13 years in post-graduate training, earning a masters degree, a PhD and board certification in plastic surgery. He finished his plastic surgery Fellowship at Emory University in 2005. He furthered his surgical training with a fellowship in Occuloplastic and aesthetic Plastic Surgery.

He is currently an Assistant Clinical Professor at the David Geffen UCLA School of Medicine in addition to being in private practice in Newport Beach CA.

Dr. Seify has published a wide range of scientific articles, book and medical textbooks chapters on the subject of plastic surgery. He has lectured and presented scientific papers nationally and overseas. Since 2008, he has been a visiting professor and guest speakers to hospitals overseas to perform surgeries on both civilians and veterans.

He is the Winner of the 2007 prestigious Sherrell Aston Award form the American Society of Aesthetic Plastic surgeons (ASAPS). He is the winner of the 2013-2017 Orange county Physicians of excellence award as well as being the winner of the 2012- 2016 US News Top Doctors In America award by Castle Connelly and US News. He is the current president elect for the Orange County Society of Plastic Surgeons.

He has been the chairman of the Board of World Wide Cancer Network since 2011. ECN/WWCN is a US based non-for profit supporting the cancer care for children and adults in Africa and the Middle East.

At the Newport Plastic and Reconstructive Surgery Associates office, Dr. Hisham Seify offers plastic and reconstructive surgery to patients across Southern California including: Irvine, Tustin, Santa Ana, Mission Viejo and Newport Beach, California.

M.D. (Secretary)

• Professor Pediatric Oncology, NCI – Cairo University.
• CEO, Children’s Cancer Hospital Foundation 57357 Group – Egypt.
• General Manager, Hospital 57357 – Egypt.

Sherif Abouelnaga has been a specialist of pediatric oncology for 25 years and received his appointment of Professor Pediatric Hematology Oncology in 2005 through the Cairo University and the National Cancer Institute. Dr. Sherif has had extensive experience in pediatric oncology as well as broad experience in program development and has been the visionary and driving force of the Children’s Cancer Hospital Egypt 57357 the first in Egypt, Africa and the Middle East,

Dr. Sherif lead the change for upgrading standards of healthcare for pediatric oncology patients at the National Cancer Institute in Cairo and adopting the most current healthcare management techniques believing that management is a science whose techniques must be applied in the overburdened healthcare system existing in Egypt

His passion for improving the lives of Egyptian children with cancer has lead him into tackling many issues from the development of the first clinical pharmacies in Egypt, upgrading blood bank and donor programs, creating proper tools for statistical gathering, fundraising, marketing, training and continuing professional development for all disciplines and levels of staff, clinical research, to facility design and program implementation.

His most significant achievement is the state of the art Children’s Cancer Hospital Egypt 57357, which was opened in 2007 after 10 years of planning and construction. It is the largest children’s cancer hospital in the world and is completely free for all patients. Under his direction, the training and development and research departments have developed comprehensive programs and strategies to ensure the position of the CCHE as a leader in quality healthcare delivery. He is the acknowledged leader in developing an entirely new concept of fundraising in Egypt and is responsible for raising over 2 billion LE for his various healthcare projects in the last 25 years

MD, PhD (Treasurer)

-Director, Pediatric Medical Neuro-Oncology, Dana-Farber/Boston Children’s Medical School

Dr. Kieran received his PhD in 1983 from the University of Alberta, Edmonton, Canada, and his MD in 1986 from the University of Calgary. He completed postgraduate training in molecular biology at the Pasteur Institute in Paris.  After a pediatric residency in Montreal at McGill University, he received postdoctoral education at Boston Children’s Hospital (BCH). In 1998, he became director of Pediatric Medical Neuro-Oncology at Dana-Farber/Boston Children’s. In addition to his role in the treatment of patients with brain tumors and the development of novel agents for the treatment of recurrent tumors, he continues to focus his laboratory efforts on angiogenesis agents from work he started in the laboratory of the late Dr. Judah Folkman.

He is a recipient of many awards including the Nick Palmer Lecture Award from the International Symposium on Pediatric Neuro-Oncology and presents lectures both at home and abroad, most recently at the Children’s Cancer Institute of Egypt and the Beijing Children’s Hospital.

Dr. Kieran is a member of the Society for Neuro-Oncology, the Society of Pediatric Research, and the American Society for Clinical Oncology. He is the editor in chief of Clinical Oncology in Adolescent and Young Adult and serves on the Editorial Board of Neuro-Oncology. Dr. Kieran is an ad hoc reviewer for many journals including the New England Journal of Medicine, Pediatric Blood and Cancer, Cancer Research, and the Journal of Pediatric Hematology/Oncology.

Education

Medical School

University of Calgary Faculty of Medicine, 1986

Calgary, CANADA

Montreal Children’s Hospital

Pediatrics – McGill University, 1989-1992

Quebec, CANADA

Fellowship

Pediatric Hematology/Oncology – Boston Children’s Hospital/Dana-Farber Cancer Institute, 1992-1995

Boston, MA

MD

• Assistant Professor, Pediatrics, Harvard Medical School
• Medical Director, Pediatric Stem Cell Transplant Unit, Boston Children’s Hospital

Dr. Lehmann attended Harvard College and received her MD from Duke University Medical School, where, after finishing a pediatric residency, she spent a year as chief resident. She completed a pediatric hematology-oncology fellowship at DFCI/Children’s Hospital Boston in 1996 and subsequently joined the faculty. In 1998, she became medical director of the Pediatric Transplant Unit at Children’s Hospital and, in 2007, was appointed clinical director of the Pediatric Stem Cell Transplant Program.

Education

Board Certification
Pediatrics, 1992
Pediatric Hematology/Oncology

Fellowship
Boston Children’s Hospital/Dana-Farber Cancer Institute, Pediatric Hematology/Oncology

Residency
Duke University, Pediatrics

Medical School
Duke University

M.B.A ( Board member )

• Co-Founder and Managing Director Qalaa Holdings Egypt

Mr. Hisham El-Khazindar (elected in 2012) is the Co-Founder and Managing Director of Qalaa Holdings, a leading investment firm in Africa and the Middle East.  Established in 2004, Citadel Capital controls investments in excess of US$ 9 billion in industries including mining, energy, logistics, agri-food and building materials. Prior to co-founding Citadel Capital in 2004, Mr. El-Khazindar was Executive Director at EFG-Hermes, the leading Middle East investment bank, where he advised on landmark M&A transactions and IPOs in the region, and where he started his career in 1996. During 1999-2000, he was on secondment to Goldman Sachs in London.

Mr. El-Khazindar is a member of the Advisory Committee of the Emerging Markets Private Equity Association, and a founding board member of the Egyptian Private Equity Association. He also serves on the Strategic Advisory Board of the American University in Cairo’s School of Business, and as a Trustee of the Children’s Cancer Hospital Egypt. He previously served as a member of US-Egyptian Business Council, as well as Chairman of the Capital Markets and Investment Committee at the American Chamber of Commerce in Egypt, and as a board member of the Egyptian Capital Markets Association.  Mr. El-Khazindar is also a member of the Young Presidents Organization, a Fellow of the Aspen Institute’s Middle East Leadership Initiative, and a member of the Aspen Global Leadership Network.  He holds a BA in Economics from the American University in Cairo (1996) and an MBA from Harvard Business School (2003).

 ( Board member )

Hospital 57357 would not have gained its position of leadership it presently enjoys without Patricia Pruden’s numerous contributions. Nurse Pruden has been an active partner and contributor to the hospital ever since its inception. Originally coming to Egypt to help Egyptian nurses upgrade-nursing care in the then newly established pediatric oncology wards at the National Cancer Institute, she soon became involved in the setting up of the first clinical pharmacy in Egypt, the blood bank upgrade, pediatric oncology protocols, and in structuring the volunteers department at the NCI. Yet, the crowning of her efforts revealed itself in the successful establishment of the Hospital. She left an impact on every aspect of its completion: fundraising, design, construction phases, policies and procedures

Early on, she was involved in 3 of the most crucial issues for 57357’s development and progress: a comprehensive long term sustainability plan, the establishment of the U.S. based fundraising affiliate, Egypt Cancer Network, the setting up of a Health Sciences Training Academy and the design of our new capacity expansion projects

Egyptian American businessman

( 57357 Honorary Chairman )

Chief economic adviser at Allianz

Mohamed A. El-Erian (Egyptian Arabic:  born August 19, 1958) is an Egyptian American businessman. He is chief economic adviser at Allianz, the corporate parent of PIMCO where he served as CEO and co-chief investment officer (2007-2014). He serves as chair of President Obama’s Global Development Council a columnist for Bloomberg View and a contributing editor to the Financial Times. Since 2014, he has served on the panel of experts that judged and selected the Financial Times/McKinsey Business Book of the Year. He is also a regular contributor to “Project Syndicate”, Yahoo Finance, Business Insider as well as Fortune/CNN and Foreign Policy. Named for 4 years in a row as one of Foreign Policy’s “Top 100 Global Thinkers,” he has written two New York Times Best Sellers, including, The Only Game in Town: Central Banks, Instability, and Avoiding the Next Collapse published in January 2016 by Random House. Together with Sir Harvey McGrath, he co-chairs the capital campaign for Cambridge University and its Colleges.

Early life and education

El-Erian was born in New York City on August 19, 1958 to an Egyptian father and a French mother. Shortly after his birth, the family moved to Egypt, where El-Erian spent some of his early childhood along with short periods in Europe where his father attended meetings of the UN law commission. In 1968, the family moved back to New York when his father took a position at the United Nations. From 1971-73, they lived in France, where El-Erian’s father was the Egyptian Ambassador to France.

After attending St John’s School, Leatherhead, a boarding school in the United Kingdom, gaining an entrance scholarship to Queens’ College, Cambridge and receiving a first class honors undergraduate degree in economics, he obtained master’s and doctorate degrees in economics from Oxford University. In June 2011, El-Erian received an honorary doctorate degree from the American University in Cairo. Following a Governing Body decision, he was admitted in December 2013 as an Honorary Fellow of Queens’ College, Cambridge University.

El-Erian has served on the Board of Trustee of several educational institutions, including Pegasus, St. Margaret School. Cambridge in America and KAUST. He co-chairs the capital campaign for Cambridge University and its Colleges.

Career

After his doctorate studies at Oxford, El-Erian settled in the US in 1983, taking a position at the International Monetary Fund in Washington, D.C. where he rose to become Deputy Director. He moved to the private sector in January 2008, working in London at Salomon Smith Barney/Citigroup before being recruited by PIMCO to lead its work on emerging markets.

After a stint at PIMCO as a managing director and head of the emerging market portfolio team, he was appointed CEO and President of Harvard Management Company, the entity that manages Harvard’s endowment and related accounts. He served as a member of the faculty of Harvard Business School. He is currently a member of the Harvard Global Advisory Council. He returned to PIMCO in December 2007 as CEO and co-CIO. As CEO of PIMCO, El-Erian was responsible for setting the strategic direction of the firm and leading its operations globally. As co-CIO with PIMCO co-founder Bill Gross, El-Erian oversaw investment policies and strategies for all the company’s portfolio management activities.

On December 21, 2012, President Obama announced the appointment of El-Erian as the chair of the president’s Global Development Council, leading the Council in its role of informing and providing advice to the President and other senior U.S. officials on global development policies and practices.

El-Erian has published widely on international economic and finance topics. He is a member of the Financial Times “A-List” of writers, has a monthly column in Foreign Policy and is a contributing editor at the FT. He is also a regular op-ed contributor to Project Syndicate. His columns have appeared in The Atlantic, Bloomberg, The Economist, “Business Insider”, Financial Times, Fortune, Newsweek, The Wall Street Journal, The Washington Post, The Financial Express, and other outlets. He is a columnist for Bloomberg. His book When Markets Collide was a New York Times and Wall Street Journal bestseller. The book won the Financial Times and Goldman Sachs Business Book of the Year Award in 2008, was named a book of the year by The Economist, and called one of the best business books of all time by The Independent.

El-Erian was named to Foreign Policy‘s list of Top 100 Global Thinkers for 2009, 2010, 2011, and 2012. He appears regularly on CNN, CNBC, and Bloomberg as well as other media outlets.

In April 2013, Foreign Policy named him as one of the 500 most powerful people on the planet. He was inducted into the Fixed Income Analysts Society Hall of Fame on April 14, 2011. In 2011, 2012, and 2013, he was included in Investment Advisor’s annual IA 25 list honoring the most influential people in and around the advisor community. In December 2012, Marketwatch named him one of “30 leaders who will set the agenda in 2013” – the publication’s annual list of the people who will shape economic currents in the coming year. In September 2013, he was recognized as the Capital Markets Personality of the Year by Africa Investor, an international investment and communications group that publishes a leading magazine for Africa’s investment decision makers.

Worth Magazine, a publication focused on high-net-worth individuals, named El-Erian to its Power 100 list – “The 100 Most Powerful People in Finance” – in 2011, 2012, and 2013. In September 2012, he was given the Creative Leadership Award by the Louise Blouin Foundation. In February 2014, the Ukleja Center honored him with the 2014 Nell and John Wooden Ethics in Leadership award. In July 2014, the Egyptian Cancer Network gave him the Lifetime Achievement Award for his support of cancer treatment and cures for children in Egypt. In November 2015, The Middle East Institute in Washington DC honored him with their Visionary Award. The award recognizes outstanding leadership in international economic and financial policy, melding creativity and vision with expertise to promote global prosperity.

El-Erian has served on several boards and committees, including the U.S. Treasury Borrowing Advisory Committee, the International Center for Research on Women, the IMF’s Committee of Eminent Persons, and the Peterson Institute for International Economics. He is currently a board member of the Carnegie Endowment for International Peace (Vice Chair), the NBER(Executive Committee), Co-chair of the Capital Campaign for the University and Colleges of Cambridge and Cambridge in America. On March 18, 2015, El-Erian was admitted as Companion of the Guild of Benefactors, Cambridge University. He is also a board member of New America, King Abdullah University of Science and Technology (KAUST) and The Pegasus School. Since 2007, he has served as chair of the Microsoft Investment Advisory Committee. He is also a member of the Council on Foreign Relations.

His philanthropic efforts over the years have emphasized education and health, including major gifts to the Children’s Cancer Hospital in Egypt as well as the University of Cambridge and Queens’ College. In October 2015, it was announced that, together with funding for studentships and new faculty positions, the El-Erian Institute for Human Behavior and Economic Policy would be established in partnership with Queens’ College and the Faculty of Economics at Cambridge. The work of the institute will look to appropriately combine economics and finance with neuroscience, psychology, politics and behavioral finance to better understand how people actually make decisions rather than how narrow theory assumes they will.

El-Erian is a widely recognized thought leader and is credited with developing the post-global financial crisis concept of the “New Normal”. Having first come up with the concept in January 2009 and after discussions with PIMCO, he wrote about it in May 2009 and presented it in several forums, including as the 2010 Per Jacobson Foundation Lecture in Washington D.C. He has published numerous articles and commentaries on topics related to the New Normal, the sovereign debt crisis in Europe, the transformative changes occurring in the Middle East, and other matters related to the global economy, policy and markets

El-Erian has spoken at many universities, public institutions and other organizations, including the University of California, Irvine, the New York Public Library, the University of Southern California, Cambridge, Oxford, the Newport Beach Public Library, and the 92nd Street Y. He has also spoken at CFA, FT, and Economist conferences. In November 2007, El-Erian was the series kick-off speaker of the MIT Egyptian Club. In 2010, he delivered the Per Jacobsson Foundation Lecture in Washington, D.C. In 2012, he was chosen to present the Homer Jones Memorial Lecture at the Federal Reserve Bank of St. Louis. In October 2012, he delivered the keynote Bagehot at The Economist‘s Buttonwood Gathering in New York. In November 2013, he delivered the luncheon speech at the IMF’s Annual Research Conference that also featured Ben Bernanke, Olivier Blanchard, Stanley Fischer, Ken Rogoff, and Larry Summers. In October 2014, he spoke at HSBC and RBS. He participated in the international symposium of the Banque de France.

He was also the keynote speaker at the 2014 CME Conference along with Ben Bernanke and Colin Powell. He has also spoken before the Economic Club of Canada, Soka University, Pro Bono Economics, Boston Security Analysts, Rabobank, the Global Financial Forum and many others. In March 2015, he was a featured speaker at the Egypt Economic Development Conference in Sharm El-Sheikh, Egypt. He also is a contributor to LinkedIn’s Influencer series and was ranked third on their top 10 influencers of the year. In November 2015, he participated in the Fortune CEO Global Summit and was the keynote speaker at the CFA Society of Chicago. In December 2015, El-Erian was the keynote speaker at the Information Management Network Conference in Scottsdale, Arizona.

On January 21, 2014, El-Erian resigned from PIMCO as of mid-March 2014. He remains a member of the parent company’s (Allianz) international executive committee, chairs its International Advisory Committee, and is an advisor to the management board.

Hala Sarhan began as a broadcaster in the Arab section of Voice of America, then worked as a reporter for the Middle East and Sedeti magazine , and then as a journalist in Kalam al-Nas magazine, which was then owned by her ex-husband Imad al-Din Adib . She also worked as a reader of an English-language bulletin from 1972 to 1976 on Egyptian television.

Her career 

Hala Sarhan has also served as a broadcaster on Egyptian TV and an anchor for a number of programs, including Transit and Egypt in the Eyes of the World, Rule of Law and the Film Archive. Dr. Hala Sarhan joined the Arab Radio and Television Network from 1993 to 1999 when it was broadcast from the Italian capital of Rome . She was the owner of mass programs on the Arab screen, including the program Ya Hala with Hala Sarhan and the program of the night with Hala Sarhan and frankly with Hala Sarhan presented on the channel art variety . After that, Dream Channel was the station and worked from 2000 to 2003 as Vice President of Dream Channel, where she presented the programs of Hawa Hwana, Hila Shaw and reality.

Hala Sarhan has a distinguished journalistic record, where she served as editor- in- chief of Ladies and Gentlemen magazine , general manager of the Arab Media Publishing and Publishing Company, general manager of Arab Radio and Television’s Media Office, Rapporteur of the Women and Family Programs Division of Arab Radio and Television, , And the Deputy Editor-in- Chief of Sedti Magazine . Hala Sarhan was a broadcaster at Voice of America and a reporter for the magazine Al-Sharq al-Awsat in Washington. She was a teacher at the Institute of Dramatic Arts and the Academy of Arts and worked as a professor at the Art Academy of the Academy of Arts and a teacher at the Academy of Arts in Giza.

She has worked in several magazines and satellite channels such as Arab Radio and Television in the Art Variety Channel, where she presented public dialogue programs such as: “Yahla” program, and then moved to Dream 2 channel, which she chaired and presented the program “In Blocked”, a political program was one of the first political programs The independent satellite TV on a special Egyptian screen, and the “Hala Shaw” program, an entertainment program. And then moved to Rotana Cinema channel, which was presided by and presented by the program “Cinema and people” and also established Rotana Zaman channel and provided on Rotana screens 6 television programs are Hala Shaw and Jana Al-Hawa and people and summer and cinema and summer and five stars and Hawa Hwana moved to the Lebanese Broadcasting Corporation Where she presented the “Five Star Channel” program. She returned to Egypt after the January 25 revolution and presented a new program, Nas Book , discussing political issues and focusing on the themes of the revolution on Rotana Egyptian channel. In a number of her television programs, Hala Sarhan hosted a number of Egyptian and Arab political figures. She also discussed a number of issues that some considered “taboo” or “difficult to discuss in Arab satellite channels”, bringing her praise and criticizing others. ^[3]

During her career, Hala Sarhan wrote several books, including:

• I write to you from the sumptuous
• Madame is temporarily suspended from service
• I love you in apricots.
• America is a big mess.
• Shehrazad said.

Ph.D.

• Professor of Pharmacy Practice (Tenured), Hampton University, School of Pharmacy

Dr. Noreddin received his Ph.D. in Pharmaceutical Sciences from the University of the Pacific, California and received research training as a visiting scholar at the Department of Medicine, Stanford University. He had postdoctoral fellowship (Pharmacokinetics and Pharmacodynamics of Antimicrobials), Department of Medical Microbiology, University of Manitoba followed by an American College of Clinical Pharmacy postdoctoral fellowship (Infectious Diseases). Dr. Noreddin’s research interest includes Pharmacoklinetic/Pharmacodynamic modeling of anti-infective and anti-cancer therapy, clinical simulation and Monte Carlo analysis and bacterial resistance in biofilm studies. Dr. Noreddin has outstanding records of scientific and academic accomplishments with multiple research funding, numerous publications in highly prestigious journals and various presentations in both national and international conferences. He served as a scientific reviewer for the NIH as well as other national and international research institutions

Research Interests

• Pharmacoklinetic/Pharmacodynamic modeling of anti-infective and anti-cancer therapy
• Clinical simulation and Monte Carlo analysis
• Bacterial resistance in biofilm studies
• Cancer epigenetic studies
• Minority health care studies

Research Focus

• Anti-infective translational research in relation to antimicrobial resistance: Our goal is to improve patient care by maximizing clinical outcomes and preventing the development of bacterial resistance.
• Anti-Cancer translational research in relation to 3D modeling and epigenetic studies: Our goal is to optimize cancer chemotherapy and overcome/reverse the development of resistance
• Approach taken by my research program is defined by both bench investigations as well as clinical simulation studies:
• In-Vitro Pharmacokinetic/Pharmacodynamic(PK/PD) modeling of anti-infective therapy
• Cutting edge in-vitro pharmacodynamic modeling techniques (for both planktonic as well as biofilm growing cells) are utilized to mimic concentration-time profile and populations encountered in patients. Our goal is to design strategies that optimize anti-infective efficacy and prevent the selection of drug resistant mutants during anti-infective therapy.
• In-Vitro Pharmacokinetic/Pharamcodynamic(PK/PD) modeling of cancer chemotherapy Advanced 3D cell culture models to evaluate administration schedules for anti-cancer agents and epigenetic studies to optimize clinical outcome.
• Mathematical modeling and clinical simulation analysis
• This translational approach involves integration of pre-clinical pharmacokinetic/pharmacodynamic data as well as early clinical pharmacokinetics/population pharmacokinetics data into mathematical modeling and Monte Carlo simulation routines. Our goal is to elucidate exposure-response relationship for target identification and optimal design of clinical trials.

Education

• BS Pharmacy, Faculty of Pharmacy , Cairo University, 1976
• M.Sc., Pharmaceutical Sciences (Biochemistry), Faculty of Pharmacy , Cairo University, 1984
• Ph.D., Pharmaceutical Sciences (Clinical Pharmacy), School of Pharmacy, University of the Pacific, 1990
• Visiting Scholar (Molecular Biology and Cancer Research), School of Medicine, Stanford University, 1990
• Fellowship, Pharmacokinetics/Pharmacodynamics (PK/PD) Research Fellowship, Faculty of Medicine, University of Manitoba, 2000
• Fellowship, Infectious Disease Research Fellowship. American College of Clinical Pharmacy, 2002
• Leadership Fellow, Academic Leadership Fellows (ALF) Program, American Association of Colleges of Pharmacy, 2008

PhD ,Am  , ASCE

Chair of Construction Management Department & Director of the infrastructure Research Center, University of North Florida, College of Computing, Engineering and Construction

PROFESSIONAL EXPERIENCE

Academic

UNIVERSITY OF NORTH FLORIDA, Jacksonville, Florida 2001- Present

Chair, Department of Construction Management (CM) and Associate Professor, responsible for departmental financial, personnel and academic program matters.  Provide the leadership role in accreditation matters. Defined and secured approval for an Infrastructure Research Center and currently serve as the Center Director.  Continue to serve as the Director of Graduate Studies in the CM MBA program. (2008-present)

Associate Professor taught various courses in the construction management academic program.  In partnership with the Coggin College of Business, had the leadership role in establishing an MBA program with a specialization in Construction Management. Research activities include an industrial research grant, a sponsored research grant and educational grants. (2001-2008)

GEORGIA SOUTHERN UNIVERSITY, Statesboro, Georgia (1998 -2001)

Assistant Professor taught various courses in the Department of Construction & Contracting, School of Technology. Was awarded Graduate Faculty Status based on teaching performance.

MERCER UNIVERSITY, Macon, Georgia (1997-1998)

Visiting Assistant Professor taught various courses in the Department of Civil Engineering, School of Engineering. Awarded Graduate Faculty Status.

UNIVERSITY OF CENTRAL FLORIDA, Orlando, Florida (1996- 1997) 

Adjunct Teacher taught various courses in the Department of Civil Engineering, College of Engineering.

Industrial

THIOKOL CORPORATION

Kennedy Space Center, Florida (1989-1993)

Space Center infrastructure design, fabrication and maintenance.

Senior System Engineer, responsible for all engineering specifications for the NASA pier used in the retrieval of rocket boosters and for the analysis and repair of the Cape Canaveral Air Force Station concrete slabs. Participated in the design of the rail system required for the transport of rocket boosters from Florida to Utah.  Other assignments included review and approval of problem reports, change orders, and modified specifications and customer liaison. (1991-1993)

System Engineer, responsible for conducting itemized testing, bench testing and integrated testing of components for the Atlas Retrieval Program. Member of the contract proposal development team in response to Air Force Request for Proposal (RFP) for Minute Man Missile Sites. (1989-1991)

AYOUBCO/PERINI CONSTRUCTION CO. (1983-1989)

Heavy civil construction companies.

Quality Control Manager managed a $300 million city concrete construction program. Responsibilities included the direction and coordination of both equipment and material across multiple construction sites, selection and purchase of project materials and the supervision of concrete mixing and pouring. Extensive experience in concrete roofs, tank surfaces, subsurface and water proofing. Extensive knowledge in areas such as concrete pouring, mix design, additives, chemicals, quality control, and concrete specifications. Performed detailed cost analyses and responsible for subcontractor negotiations.

ICAT CONSTRUCTION CO. New York and Cairo, (1979-1983)

Commercial Construction Company.

Project Manager & Assistant General Construction Manager managed the concrete construction of two high-rise towers ($40M). Responsibilities included the management of concrete construction operations including planning, bidding, project schedules, cost analysis, daily site operations and vendor contractor negotiations and claims settlement.

TROUILLARD CORP., Paris, France (1976-1979)

Commercial Construction Company.

Quality Control Engineer, responsible for testing concrete slabs, other concrete structures and the design and control of various concrete mixes. Extensive knowledge of pre-stressed, pre-cast concrete and pre-fab with the Pre-fab Trouillard Concrete System.

RESEARCH PROGRAMS & DONATIONS

• Historical Building Restoration in the Jacksonville, Florida Area, UNF Board of Trustees, $5,000, (September 2002).
• Consulting contract for the selection of a specialized concrete sub-contractor, Stone

Wood Association, $6,500. (August 2004).

• Concrete inspection and testing, Stone Wood Association, $25,000 (October 2005).
• Internet Project Management Software, Primavera Corp., $250,000 (August, 2003)
• Corporate fund raising for CM Department, ~$100,000.
• Modified the CM curriculum to incorporate a new TLO course, Industrial Construction II, with a focus on modifying marine shipping containers for UNF Habitat applications such as housing, shelters, classrooms and libraries. CM students perform the design and construction modifications to the containers. The first two UNF Habitat Containers are to be shipped to South America. Others are in “construction”.

Received TLO grant and other university grants ~ $17,500 (2010 & 2011).

• Community Based Learning Projects:

o   Alden Road Exceptional Student/Rotary&

o   YCC HOUSING/Builders Care

o   School for orphans in the Philippines

• Gateway project downtown Jacksonville

EDUCATION

• University of Central Florida, Ph.D., Engineering (1996), Dissertation “Constructability Assessment Using Fuzzy Logic Modeling”
• The American University (AUC), Diploma (~MS) Management (1977)
• Cairo University, MS, Engineering (1978)
• The American University (AUC), BS , Materials Eng. (1975)
• Acrow Corp., Certificate, Industrial Training
• NASA, Training, Software Applications

OTHER

• Nominated for undergraduate teaching award.
• Nominated for senior faculty International award.
• Best Paper Award at ASC conference, Clemson University, N.C., 2003
• Award Paper Presentation at IAMOT conference, Miami, FL, 2010

M.D.

•  Associate Professor of Orthopedic Surgery, Emory University.

Dr. Labib has a particular interest in problems and procedures of the knee, ankle, and foot. He is the head team physician for the athletic programs at Oglethorpe University, Spelman College, and Georgia Perimeter College. He is also an orthopedic consultant to Georgia Tech and Emory University.

He has lectured both nationally and internationally at many orthopedic meetings. His research has been published in several journals, including Arthroscopy, Foot and Ankle International and the American Journal of Orthopedics as well as numerous video presentations and book chapters. Dr. Labib is Board Certified in orthopedic surgery with additional subspecialty certification in Sports Medicine Surgery. For the past 3 years, Dr. Labib has been nominated by his peers as one of “America’s Top Doctors” as tracked by CastleConnelly.com.

Clinical Interests

• ACL surgery
• ankle
• Ankle Surgery
• arthritis
• arthroscopic surgery
• Cartilage Reconstruction/Repair
• cartilage transplant
• foot
• Foot Surgery
• knee arthroplasty
• knee replacement
• Knee Replacement Sugery
• knee surgery
• knee surgery-under 50
• lower extremity reconstruction
• patella stablization
• plantar fasciotomy
• platelet rich plasma
• Platelet-Rich Plasma (PRP) Therapy
• sports medicine
• tendon/ligament injuries

Academic Profile

Training

MEDICAL SCHOOL

Ain Shams University, Cairo, Egypt
1980

INTERNSHIP

Royal Victoria Hospital, Quebec, Canada
1986

RESIDENCY

Jewish General Hospital, Montreal, Canada
1991

FELLOWSHIP

University Hospital, London, Canada
1992

American Sports Medical Institute, Birmingham, AL
1999

Royal Victoria Hospital, Quebec, Canada
1987

Professional Memberships

American Academy of Orthopaedic Surgeons (AAOS.org)

American Orthopaedic Foot and Ankle Society (AOFAS.org)

American Orthopaedic Society of Sports Medicine (AOSSM.org)

American Sports Medicine Institute, Birmingham (ASMI.org)

Member, Georgia Orthopaedic Association

Past President, Georgia Orthopaedic Foot & Ankle Society

Honors & Awards

America’s Top Doctors
by CastleConnelly.com 2007,2008,2009

Best Doctors in Atlanta
Atlanta Magazine, August 2001

Best Foot and Ankle Paper
Kelly Orthopaedic Society, Emory University 2000

Eugene Rogala Best Resident Research Award
McGill 1999

FORMER U.S. ASSOCIATE DEPUTY SECRETARY OF ENERGY, President of Fahmy Hudome International (FHI)

As an internationally recognized expert in Middle East and North Africa affairs, Randa Fahmy Hudome utilizes her 25 years of professional experience, including service in the executive and legislative branches of the U.S. Government, to provide superior advice and counsel to her clients. With a particular focus on Egypt, Libya and Tunisia, Randa builds upon her legal and public policy skills to assist global companies interested in accessing Middle East and North Africa markets.

In 2003, Randa launched Fahmy Hudome International (FHI), a strategic consulting firm which provides critical advice and counsel to Fortune 500 companies, foreign governments, media organizations, and private sector entities with business interests in the Middle East and North Africa. Prior to founding FHI, Ms. Fahmy Hudome was appointed by President George W. Bush to serve as the United States Associate Deputy Secretary of Energy. Working with the White House and the Departments of State and Commerce, she developed and implemented the Bush Administration’s international energy policy. Randa was also the point person at the Department of Energy for increased advocacy on behalf of American energy companies seeking business around the globe. From 1995-2001, Randa served as Counselor to United States Senator Spencer Abraham (R-MI). During the six years she spent in the legislative branch, she was credited with shaping many pieces of legislation that affected U.S. interests abroad, including financial assistance to U.S. allies in the Middle East.

Prior to her government service, Randa was a practicing attorney with the law firm of Willkie, Farr and Gallagher, where she specialized in the areas of international trade and corporate litigation. She received her juris doctor from the Georgetown University Law Center, where she held the post of Administrative Editor of The Georgetown Journal of International Law.

Randa’s expertise in international economic policy and energy has been sought by the U.S. Secretary of State, who appointed her to serve on the U.S. State Department Advisory Committee on International Economic Policy, and by the Secretary of Energy who appointed her to serve on the U.S. Secretary of Energy Advisory Board. Ms. Fahmy Hudome’s opinions on international diplomacy have been published in the Wall Street Journal, and she appears frequently as an expert analyst on NBC’s Today Show, MSNBC, Fox News, CNN, and Al-Jazeera.

MD, FACS

• J.C. Walter Jr. Presidential Distinguished Chair & Director, J.C. Walter Jr. Transplant Center
• Professor of Surgery, Institute for Academic Medicine
• Full Member, Research Institute
• Program Director, Transplant Surgery Residency, Department of Surgery Houston Methodist Weill Cornell Medical College

Dr. Gaber is the Director of Transplantation and Vice Chair for Administration and Faculty Affairs in the Department of Surgery in The Methodist Hospital Physician Organization in Houston, TX. Before joining The Methodist Hospital Physician Organization in May 2007, he was a Professor in the Department of Surgery and Director of the Transplant Division at the University of Tennessee in Memphis, and is still currently a Professor in the College of Nursing and Pharmacy of the University of Tennessee in Memphis. He also held the Chair of Excellence in Transplantation for the Baptist Memorial Health Care Foundation. He received his medical degree from the Ain shams University School of Medicine in Cairo, Egypt and completed an internship and residency in general and pediatric surgery at Ain shams University Hospital. He also completed a residency in general surgery at Boston University Medical Center and clinical and research transplant fellowships at the University of Chicago in Illinois.

Dr. Gaber has had a long career in transplantation research including being the Principal Investigator of several NIH-funded research projects, including the Treatment of Type 1 Diabetes by Gene Therapy Approaches. Dr. Gaber has extensive clinical experience in managing and designing immune suppression protocols. He has also led several multicenter clinical studies, phases II-IV. Dr. Gaber was also a Councilor at Large for the American Society of Transplant Surgeons. He serves on the editorial boards of Transplantation, Cancer Molecular Biology, and Graft. Dr. Gaber is a two-time recipient of the Gift of Life Award by the National Kidney Foundation West Tennessee Chapter and the recipient of the 2002 Memphis Business Journal Health Care Physician Hero Award. Dr. Gaber has authored or co-authored more than 200 journal articles, 13 book chapters, and almost 300 abstracts that have been presented and/or published. He is an invited lecturer and presenter at numerous US and international meetings

Ph.D.

• Regents’ Professor and Julius Brown Chair
• Egyptian-Americanchemical physicist
• A leading nanoscience researcher

Born 8 May 1933 – Zifta, Egypt) is an Egyptian-American chemical physicist, a leading nanoscience researcher, a member of the National Academy of Sciences and a US National Medal of Science laureate. He is also known for the spectroscopy rule named after him, the El-Sayed rule. He earned his B.Sc. from Ain Shams University Faculty of Science in the 1953.[1] El-Sayed earned his doctoral degree from Florida State University working with Michael Kasha, the last student of the legendary G. N. Lewis

He spent time as a researcher at Harvard University, Yale University and the California Institute of Technology before joining the faculty of the University of California at Los Angeles in 1961. He is currently the Julius Brown Chair and Regents Professor of Chemistry and Biochemistry at the Georgia Institute of Technology. He heads the Laser Dynamics Lab there.

El-Sayed is a former editor-in-chief of the Journal of Physical Chemistry.

El-Sayed and his research group has contributed to many important areas of physical and materials chemistry research. El-Sayed’s research interests include the use of steady state and ultra-fast laser spectroscopy to understand relaxation, transport and conversion of energy in molecules, in solids, in photosynthetic systems, semiconductor quantum dots and metal nanostructures. The El-Sayed group has also been involved in the development of new techniques such as magneto photo selection, picosecond Raman spectroscopy and phosphorescence microwave double resonance spectroscopy.

A major focus of his lab is currently on the optical and chemical properties of noble metal nanoparticles and their applications in nanocatalysis, nanophotonics and nanomedicine. His lab is known for the development of the gold nanorod technology.

Professor El-Sayed has over 500 publications in refereed journals in the areas of spectroscopy, molecular dynamics and nanoscience. Prof. El-Sayed has supervised the research of over 70 PhD students, 35 postdoctoral fellows and 20 visiting professors, several of whom hold key positions in the scientific community.

Dr. Mostafa El Sayed’s son, Dr. Ivan El-Sayed, the Professor of Tumor Surgery at the University of California, took part in applying these outcomes on cancerous cells of some animals.

Honors

For his work in the area of applying laser spectroscopic techniques to study of properties and behavior on the nanoscale, El-Sayed was elected to the National Academy of Sciences in 1980, and in 2002, he won the Irving Langmuir Award in Chemical Physics. He has been the recipient of the 1990 King Faisal International Prize (“Arabian Nobel Prize”) in Sciences, Georgia Tech’s highest award, “The Class of 1943 Distinguished Professor”, an honorary doctorate of philosophy from the Hebrew University, and several other awards including some from the different American Chemical Society local sections. He was a Sherman Fairchild Distinguished Scholar at the California Institute of Technology and an Alexander von Humboldt Senior U.S. Scientist Awardee. He served as editor-in-chief of the Journal of Physical Chemistry from 1980–2004 and has also served as the U.S. editor of the International Reviews in Physical Chemistry. He is a Fellow of the American Academy of Arts and Sciences, a member of the American Physical Society, the American Association for the Advancement of Science and the Third World Academy of Science. Mostafa El-Sayed was awarded the 2007 US National Medal of Science “for his seminal and creative contributions to our understanding of the electronic and optical properties of nanomaterials and to their applications in nanocatalysis and nanomedicine, for his humanitarian efforts of exchange among countries and for his role in developing the scientific leadership of tomorrow.”[4] Dr. Mostafa was also announced to be the recipient of the 2009 Ahmed Zewail prize in molecular sciences.

Ph.D

• Director of the Center for Remote Sensing and Research
• Professor at the Departments of Archaeology and Electrical & Computer Engineering, and Associated Faculty at the Department of Earth and Environment, Boston University, Boston, MA, U.S.A.

Dr. Farouk El-Baz is Research Professor and Director of the Center for Remote Sensing at Boston University, Boston, MA, U.S.A. He is Adjunct Professor of Geology at the Faculty of Science, Ain Shams University, Cairo, Egypt. He is also a Member of the Board of Trustees of the Geological Society of America Foundation, Boulder CO. He was born on 1 January 1938 in the Nile Delta town of Zagazig. Twenty years later, he received a B.Sc. in chemistry and geology from Ain Shams University, followed by a scholarship for graduate study. In 1961, he received a M.S. degree in geology from the Missouri School of Mines and Metallurgy; his performance won him membership in the honorary society of Sigma Xi. In 1964, he received a Ph.D. in geology from the University of Missouri after conducting research in 1962-1963 at the Massachusetts Institute of Technology (MIT), Cambridge MA. In 1989, he received an Honorary Doctor of Science (D.Sc.) degree from the New England College, Henniker NH.

Dr. El-Baz taught geology at Assiut University, Egypt (1958-1960) and the University of Heidelberg, Germany (1964-1965). He joined the Pan American – U.A.R. Oil Company in 1966, where he participated in the discovery of El-Morgan, the first offshore oil field in the Gulf of Suez.

From 1967 to 1972, Dr. El-Baz participated in the Apollo Program as Supervisor of Lunar Science Planning at Bellcomm Inc., a division of AT&T that conducted systems analysis for NASA Headquarters in Washington DC. During these six years, he was Secretary of the Landing Site Selection Committee for the Apollo missions to the Moon, Principal Investigator of Visual Observations and Photography, and Chairman of the Astronaut Training Group. His outstanding teaching abilities were confirmed by the Apollo astronauts. While circling the Moon for the first time during Apollo mission 15, Alfred Worden said, “After the King’s [Farouk’s nickname] training, I feel like I’ve been here before.”

During the Apollo years, Dr. El-Baz joined NASA officials in briefing members of the press on the results of the lunar missions. His appeal rested in a unique ability to simplify complex issues in clear, succinct and easily understood words. His remarks on the scientific accomplishments were regularly quoted by the media during the Apollo missions.

In Episode 10 (“Galileo Was Right”) of the TV series “From the Earth to the Moon,” produced by Tom Hanks for HBO, his role in the training of the Apollo astronauts was featured in a segment entitled: “The Brain of Farouk El-Baz.” In his honor, the popular television program “Star Trek: The Next Generation” featured a shuttle craft named “El-Baz.”

After the Apollo Program ended in 1972, Dr. El-Baz joined the Smithsonian Institution in Washington DC to establish and direct the Center for Earth and Planetary Studies at the National Air and Space Museum. At the same time, he was elected as a member of the Lunar Nomenclature Task Group of the International Astronomical Union. In this capacity, he continues to participate in naming features of the Moon as revealed by lunar photographic missions.

In 1973, NASA selected him as Principal Investigator of the Earth Observations and Photography Experiment on the Apollo-Soyuz Test Project (ASTP), the first joint American-Soviet space mission of July 1975. Emphasis was placed on photographing arid environments, particularly the Great Sahara of North Africa and the Arabian Peninsula, in addition to other features of the Earth and its oceans.

Emphasizing the study of the origin and evolution of arid landscapes, he collected field data during visits to every major desert in the world. One of his significant journeys took place, soon after the United States and China had normalized relations in 1979, when he coordinated the first visit by American scientists to deserts in northwestern China. The six-week journey was chronicled in National Geographic and the Explorers Journal. His research on the origin and evolution of the desert resulted in his election as a Fellow of the American Association for the Advancement of Science (AAAS).

Prior to embarking on extensive field trips to harsh deserts, Dr. El-Baz analyzed space photographs utilizing innovative techniques to select sites for detailed ground investigation. He first used this approach in the Western Desert of Egypt and soon applied the method to study deserts in Kuwait, Qatar, United Arab Emirates (U.A.E.), Sultanate of Oman, the deserts of China, and the Rajasthan of India.

Dr. El-Baz served his native land as Science Advisor to the late Egyptian President Anwar Sadat from 1978 to 1981. Because of population growth and the attendant food requirements, Sadat believed that Egyptians should not continue to be confined within the Nile Valley and must reclaim more land from the desert.

El-Baz was assigned the task of selecting desert tracts to develop, without detriment to the environment. He traveled to Egypt’s far corners and described each region’s natural resources and how they could be most wisely used. The many projects that began during those four years continue to help the people of Egypt today. In 1995, the Governor of the Province of Dakahliya, in the eastern part of the Nile Delta, gave him the “Distinguished Son of Dakahliya Award” and inaugurated the “Farouk El-Baz Primary School” in his ancestral village of Toukh El-Aqlam.

His desert research, spanning over 25 years, helped in dispelling the public misconception that deserts were man-made and explained how arid lands originated and evolved in response to global climatic variations. His research methods are now commonly replicated in desert studies throughout the world.

From 1982 to 1986, Dr. El-Baz was Vice President of Science and Technology at Itek Optical Systems, Lexington MA. He oversaw the application of data from the Space Shuttle’s Large Format Camera. The photography of this advanced system assisted greatly in El-Baz’s program of desert study from space.

He was elected Fellow of the Third World Academy of Sciences (TWAS) in 1985, and became a member of its Council in 1997. He represents the Academy at the Non-Governmental Unit of the Economic and Social Council (ECOSOC) of the United Nations (UN), New York.

In 1986, Dr. El-Baz joined Boston University as Director of the Center for Remote Sensing to promote the use of space technology in the fields of archaeology, geography and geology. Under his leadership, the Center has grown to become a leading force in the applications of remote sensing technology to environments around the world. In 1997, NASA selected it as a “Center of Excellence in Remote Sensing.”

Research at the Center has particularly pushed forward the frontiers of applying remote sensing in archaeology. For example, Dr. El-Baz developed a methodology for nondestructive investigation of a sealed chamber containing a disassembled boat at the base of the Great Pyramid in Giza, Egypt. He reported the results of this unique investigation in National Geographic and American Scientist, as well as many print, radio and television interviews. He also contributed an article on worldwide applications of remote sensing to archaeology in the “1991 Yearbook of Science and the Future” of the Encyclopedia Britannica, and another to the August 1997 issue of Scientific American.

The Gulf War of 1991 presented an opportunity for Dr. El-Baz to disseminate knowledge of the desert terrain with emphasis on the effects of environmental disturbances. As chairman of the committee on Environmental Hazards and Global Change of the TWAS, Dr. El-Baz led a team of scientists on a fact-finding mission to six Gulf States. His findings were reported in the media throughout the world including on the Evening News of the British Broadcasting Corporation (BBC) and interviews on CBS News and CNN. Print media interviews with Dr. El-Baz appeared in the New York Times, Washington Post, Boston Globe, and newsmagazines such as Time and Newsweek.

Throughout his career, Dr. El-Baz has succeeded in conveying the excitement of scientific research and the importance of using advanced technology. One of his efforts resolved the 1995 controversy about the crowd size in Washington DC’s “Million Man March”. He estimated the number of participants in the march using the same computer techniques applied to counting sand dunes in the desert.

Dr. El-Baz is well known as a pioneer in the application of space-borne data to ground-water exploration. He utilizes satellite images to identify fracture zones, and radar data to reveal sand-buried courses of former rivers. He successfully applied these methods in the arid lands of Egypt, Somalia, Sudan and Oman. His findings alleviated shortages of ground water in areas of dire need. This won him the M.T. Halbouty Human Needs Award of the American Association of Petroleum Geologists (AAPG). He was also appointed Senior Advisor to the World Bank/UN World Commission on Water for the 21st Century.

He is an accomplished author or editor of twelve books, including Say it in Arabic, The Moon as Viewed by Lunar Orbiter, Apollo Over the Moon, Egypt as Seen by Landsat, Deserts and Arid Lands, The Gulf War and the Environment, and Atlas of the State of Kuwait from Satellite Images. He has contributed over 200 scientific papers to professional journals, supervised numerous graduate students, and lectured in academic institutions and research centers worldwide.

Dr. El-Baz is a member of the United States National Committee for Geological Sciences of the National Academy of Sciences. He serves on the Board of Trustees of the new Alexandria Library, the Arab Science and Technology Foundation, the Egyptian Center for Economic Studies, the Egyptian-American Affairs Council, the Moroccan-American Council, the World Affairs Council of Boston, as well as the editorial boards of several international professional journals. He is a member of many national and international professional societies and a Fellow of the Geological Society of America, the American Association for the Advancement of Science, the Royal Astronomical Society (London), and the Explorers Club (New York).

He has won numerous honors and awards, including NASA’s Apollo Achievement Award, Exceptional Scientific Achievement Medal, and Special Recognition Award; the University of Missouri Alumni Achievement Award for Extraordinary Scientific Accomplishments; the Certificate of Merit of the World Aerospace Education Organization; the Golden Door Award of the International Institute of Boston; the Award for Public understanding of Science and Technology of the American Association for the Advancement of Science, and the Arab Republic of Egypt Order of Merit – First Class. He also serves as President of the Arab Society for Desert Research.

In 1999, the Geological Society of America (GSA) established the “Farouk El-Baz Award for Desert Research,” an annual award aimed at encouraging excellence in arid land studies.

Ph.D.

• Professor of Computer Engineering, and Dean of Educational Affairs Arab Academy for Science, Technology & Maritime Transport (AASTMT)

Dr. Mohamad Abou El-Nasr was born in Beirut, Lebanon in 1971. He is a Professor and Head of Computer Engineering department, Arab Academy for Science, Technology & Maritime Transport (AASTMT), Alexandria, Egypt. He is also affiliated with Virginia Polytechnic Institute and State University where he works as an adjunct professor in the Bradley Department of Electrical and Computer Engineering – Virginia Tech- Middle East and North Africa (VT-MENA) program.
Dr. Abou El-Nasr received the B.Sc. degree with highest honor from Arab Academy for Science, Technology & Maritime Transport (AASTMT) in 1995. He earned both his Ph.D. and M.Sc. in Electrical and Computer Engineering in 2003 and 1999, respectively, from the School of Electrical and Computer Engineering at Georgia Institute of Technology, Atlanta GA, USA. While at Georgia Tech, he received the International Graduate Student Scholarship and M.S. Dean’s Honor List of the Electrical and Computer Engineering Department in 1998 and 1999, respectively. He also received the Multi-disciplinary program award in manufacturing in 2003. He joined the faculty at the Arab Academy for Science, Technology and Maritime Transport (AASTMT) in June 2003, and became the Head of Computer Engineering department in 2008.
Dr. Abou El-Nasr works on multiple areas, and his research spans a wide spectrum of topics in the field of computer and communications networks. His research group works on different projects related to UWB systems, physical layer issues in wireless networks, VANET security issues, human locomotion tracking, wireless ad-hoc networks, intelligent semantic web, cross-layer design for moving in mobile and ad-hoc networks, embedded systems design and FPGA implementation of face detection and recognition algorithms as well intrusion detection systems. He graduated one Ph.D. and fifteen master students. He is currently supervising four Ph.D. and ten master students.

Dr. Abou El-Nasr has coauthored two book chapters and more than 40 papers in refereed journals and renowned conferences. He received many awards for his distinguished research including, the third place in the wireless design contest that was held by Lantronix at the Embedded system Design conference CA in 2007, Computer Engineering Department at AASTMT distinction award in 2004, AASTMT outstanding scientific research award for distinguished publications in international and highly recognized periodicals (four times), AASTMT college of engineering graduation project competition (received 2nd place out of 93 projects admitted to the competition) in 2011, and he was the supervisor of two recipients of the young scientist awards at the URSI general assembly in 2008 and 2011.

Dr. Abou El-Nasr serves as a reviewer for multiple international conferences and journals, and a permanent Technical Program Committee (TPC) member of the International Conference on Computer Theory and Applications (ICCTA). He is also the Middle East and Africa Chapter Head, Institute of Computer Sciences, Social Technologies and Telecommunications. He is a current Member of IEEE, IEEE communications and computer societies, a member of ACM, and a member of ASEE.

MD

• Assistant Professor, Pediatrics, Harvard Medical School
• Medical Director, Pediatric Stem Cell Transplant Unit, Boston Children’s Hospital

Dr. Lehmann attended Harvard College and received her MD from Duke University Medical School, where, after finishing a pediatric residency, she spent a year as chief resident. She completed a pediatric hematology-oncology fellowship at DFCI/Children’s Hospital Boston in 1996 and subsequently joined the faculty. In 1998, she became medical director of the Pediatric Transplant Unit at Children’s Hospital and, in 2007, was appointed clinical director of the Pediatric Stem Cell Transplant Program.

Education

Board Certification
Pediatrics, 1992
Pediatric Hematology/Oncology

Fellowship
Boston Children’s Hospital/Dana-Farber Cancer Institute, Pediatric Hematology/Oncology

Residency
Duke University, Pediatrics

Medical School
Duke University

MSN, RN, CPNP

• Pediatric Nurse PractitionerDana-Farber Cancer Institute, Harvard Medical School, Boston

Ms. Christine A Chordas is a Nurse Practitioner based out of Boston, Massachusetts and her medical specialization is Nurse Practitioner – Pediatrics. She practices in Boston, Massachusetts and has the professional credentials of PNP. The NPI Number for Ms. Christine A Chordas is 1104909472 and she holds a License No. 243313 (Massachusetts).

Certifications & Licensure

MA State Medical License2001 – 2016

MD

• Medical Director of the hematology/oncology department at Dayton Children’s

Dr. Ayman El-Sheikh is the medical director of the hematology/oncology department. He leads a team of pediatric specialists, nurses, social workers, child life specialists and other care professionals who ensure that children battling cancer or blood disorders get the multidisciplinary approach that ensures that their unique medical and psychological needs are met. Dr. El-Sheikh is board certified in pediatrics and pediatric hematology/oncology. He is especially interested in blood and marrow transplants, solid tumor treatment, education and research. Dr. El-Sheikh joined Dayton Children’s in 2015 from the University of Iowa Children’s Hospital in Iowa City, where he was the director of the pediatric blood and marrow transplant program, the institutional principal investigator for the Children’s Oncology Group (COG) and the medical director of the inpatient ward. He was also a clinical assistant professor of pediatric hematology/oncology at Carver College of Medicine at the University of Iowa, as well as on the admissions committee.

Education and Training

Medical School:

Tanta University, Egypt

Internship:

UMDNJ Camden NJ

Residency:

Children’s Regional Hospital, Camden, New Jersey – Pediatrics

Fellowship:

Iowa Children’s Hospital, Iowa City Pediatric hematology/oncology, blood, and marrow transplant

Board Certification:

Pediatrics
Pediatric hematology/oncology

Professorship:

Associate professor

MD

• Pediatric Neuro -radiologist
• Assistant Professor of Radiology, Harvard Medical School

Education

Medical School

Mount Sinai Medical School, 1991

New York, NY

Internship

University of Pennsylvania, 1991-1992

Philadelphia, PA

Residency, Diagnostic Radiology

Beth Israel Hospital, 1992-1996

Boston, MA

Fellowship, Women’s Imaging

Beth Israel Hospital, 1996-1997

Boston, MA

Fellowship, Neuroradiology

Brigham & Women’s Hospital, 1997-1998

Boston, MA

Certifications

Radiology, Neuroradiology

MD

• An international leader in pediatric solid tumor research
• Director, International Outreach Program, JudeChildren’s Research Hospital

Rodriguez-Galindo serves as the International Outreach Program director and an executive vice president. He will also chair the newly created Department of Global Pediatric Medicine and hold the Four Stars of Chicago Endowed Chair in International Pediatric Research.

A native of Spain, Rodriguez-Galindo came to St. Jude in 1994 as a postdoctoral fellow and served as a clinical researcher and faculty member for more than a decade. He focused on developing new therapies for retinoblastoma, sarcomas and rare childhood cancers.

He returns to St. Jude from Dana-Farber Cancer Institute and Boston Children’s Hospital, where he was director of the Pediatric Solid Tumor Program, medical director of the Clinical and Translational Investigations Program, and director of the Global Health Initiative in Pediatric Cancer and Blood Disorders. He also served as professor of Pediatrics at Harvard Medical School

Education

MD – Autonomous University of Barcelona, Spain

Honors & Awards

• 2016-2017 Baldrick’s Consortium Research Grant
• 2014 Innovation Award, Dana-Farber Cancer Institute
• 2010 Holcombe E. Grier Award for Excellence in Teaching, Dana-Farber/Children’s Cancer Center, Harvard Medical School
• 2004-2006 Translational Research Award, Children’s Oncology Group
• 2004 Outstanding Clinical of the Year, St. Jude Children’s Research Hospital
• 2001 Imminent Scientist and Outstanding Scholar of the Year, International Research Promotion Council (Asia-Pacific Chapter)
• 2000-2001Teaching Award, Pediatric and Medicine/Pediatric House Staff, University of Tennessee
• 1998-1999Teaching Award, Pediatric and Medicine/Pediatric House Staff, University of Tennessee

Hospital Saint Joan de Déu, Barcelona, Spain

• Scientific director of the Oncology and hematology area at SJD Barcelona Children’s Hospital, and director of the developmental tumors laboratory at the same hospital.

Dr. Jaume is a member of different national and international scientific societies, including the International Paediatric Oncology Society, which has awarded me the Schweisguth Prize, and the American Society of Clinical Oncology (ASCO), which in 2000 honoured me with the young investigator award (YIA), as well as the Career Development Award (CDA). In 2011, I was the recipient of the annual BBVA Foundation Award and in 2006 of the First Prize of the Spanish Association against Cancer (AECC) award for the study of child cancer.

EDUCATION

• PhD in Medicine Faculty of Medicine. Autonomous University of Barcelona (UAB), 2003.
• Pediatrics specialist, Hospital Vall d’Hebron, 1995.
• Bachelor’s Degree in Medicine and Surgery, Faculty of Medicine. University of Barcelona, 1990.

INTERNATIONAL EXPERIENCE

• Memorial Sloan-Kettering Cancer Center, Molecular Pathology of Paediatric Tumor Fellowship, New York, USA. 1999-2001.
• The New York Hospital Cornell University and Memorial Sloan-Kettering Cancer Center Combined Fellowship Programs (peds Hem/Onc), New York, USA. 1996-1999.

SCIENTIFIC ACTIVITY

• Coordinator of the Developmental Cancer research area.
• Author of over 75 peer-reviewed articles in his specialty and 6 book chapters in national and international publications.

Reviewer of the journals: Cancer, Laboratory Investigation, Oncogene, Paediatric Blood & Cancer, British Journal of Cancer, Molecular Cancer, Paediatrics, International Journal of Cancer, Chemotherapy and Future Oncology.

MD

• Director, Pediatric Neuro-Oncology Outcomes Clinic
  Senior Physician
• Assistant Professor of Pediatrics, Harvard Medical School

Board Certification
Pediatric Hematology/Oncology

Fellowship
Boston Children’s Hospital/Dana-Farber Cancer Institute, Pediatric Neuro-Oncology, 2005
Rhode Island Hospital, Hasbro Children’s Hospital, Pediatric Hematology/Oncology, 2004

Residency
Floating Hospital for Children at Tufts Medical Center, 2001

Internship
Floating Hospital for Children, Boston, MA, 1999

Medical School
Virginia Commonwealth University, Medical College, 1998

 RN Dana-Farber Cancer Institute, Harvard Medical School, Boston

MHA, MSN, RN

Director, Pediatric Oncology Nursing and Clinical Services, Dana-Farber
Director, Nursing/Patient Services, Pediatric Oncology/Hematology/Stem Cell Transplant, Children’s Hospital Boston

Biography

I have been an oncology nurse at the Dana-Farber/Children’s Hospital Cancer Center (DF/CHCC) for almost 30 years. I was an oncology staff nurse for 10 years and am presently the nurse director of the inpatient Hematology/Oncology/Stem Cell Transplant program at Children’s Hospital Boston and the outpatient Jimmy Fund Clinic at the Dana-Farber Cancer Institute. I have also worked to develop the DF/CHCC Oncology Community Outreach Program that involves the Back to School Program, a Hospital to Home visit from a dedicated DF/CHCC staff nurse visiting all eligible newly diagnosed patients and community education to homecare agencies. During the last few years, I have been involved in global health and am the nurse advisor and educator to the Children’s Cancer Hospital Egypt and National Guard Hospital in Saudi Arabia. Most recently, I am participating in the DFCI/ Partners in Health oncology education and training efforts in Rwanda.

Education and Training
Laboure College, Associate in Science and Nursing, 1984
Stonehill College, BA, 1977
Simmons College, MS, Healthcare Administration, 2004
St. Joseph’s College, Masters in Nursing Education, 2011

Awards

MVP Award, Alex’s Team Foundation, 2007

Patrick Faolan McDonogh Appreciation Award, 2006

Massachusetts Soceity of Health-System Pharmacists Award, 2003

MD, MPH

• Attending Psychiatrist
• Assistant Professor in Psychiatry, Harvard Medical School
• Professor Neurosurgery, Harvard Medical School

Education

Certifications

Psychiatry, Public Health, Child and Adolescent Psychiatry

MD, FRCSC

• Director, Pediatric Neurosurgical Oncology Dana Farber/Boston Children’s Hospital Cancer Center; Director, QI Program Department of Neurosurgery

I am a pediatric neurosurgeon committed to the best possible outcomes for children with brain tumors at Boston Children’s Hospital, Dana-Farber Cancer Institute and through my efforts to raise standards of care here and abroad.

I completed my residency at the University of Ottawa, in Canada, and was a fellow in pediatric neurosurgery at the Hospital for Sick Children in Toronto and in Neuroscience at the University of Pennsylvania. My joint training in both neurosurgery and basic neuroscience has helped me to treat patients at the highest level and conduct research that is forging new ground in our understanding of brain cancer biology.

I am a director of the combined program in pediatric neurosurgical oncology at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. I co-direct Boston Children’s Hospital’s Brain Tumor program, a multidisciplinary program that is a model nationwide and that I helped to establish.

Since 1992, I have been in charge of the Neurosurgery Department’s Quality Improvement program. I have developed an outcomes database for the Department of Neurosurgery and am working on standardizing outcome measures in our field. My work in this area aims to establish national outcomes measures for pediatric neurosurgical procedures for the first time. Boston Children’s Hospital’s industry-leading intraoperative MRI technology has contributed to this effort, allowing me to see whether we are accomplishing our goals as  surgery progresses, and helping to set new benchmarks and leading to the best possible outcomes.

I am committed to improving care overseas, through my relationship with CCHE (Children’s Cancer Hospital Egypt) 57357 in Cairo, Egypt  We have established a “twinning training program” between Boston Children’s/Dana Farber Cancer Institute and CCHE 57357 in Pediatric Oncology and are developing a similar training program in pediatric neurosurgery.

I have been honored to receive some of my field’s most prestigious honors, including the Young Investigator Award from the American Association of Neurological Neurosurgeons in 1996 and the Women in Medicine prize in 2009 from Boston Children’s Hospital.

Education

Undergraduate

Medical Academy, 1977

Sofia, Bulgaria

Medical School

University of Toronto Faculty of Medicine, 1980

Toronto, Canada

Internship

Saint Joseph’s Health Centre, 1980-1981

Toronto, Canada

Residency

Neurosurgery-University of Ottawa, 1981-1986

Ottawa, Canada

Fellowship

Pediatric Neurosurgery-Hospital for Sick Children, 1987-1988

Toronto, Canada

Fellowship

Neuroscience Research-David Mahoney Institute of Neuroscience, University of Pennsylvania, 1988-1990

Philadelphia, Pennsylvania
Certifications

• ABNS – American Board of Neurological Surgery
• ABPNS – American Board of Pediatric Neurological Surgery
• Neurology (FRCSC)
• Neurological Surgery
• Pediatric Neurological Surgery

MD

• Associate Professor, Division of Medical Oncology

Dr. Gore joined the University of Colorado School of Medicine faculty as an Assistant Professor in July 2001. She trained in Pediatrics at Children’s National Medical Center and the University of Colorado. She completed her fellowship training in pediatric hematology/oncology/bone marrow transplantation at the University of Colorado Cancer Center and Children’s Hospital Colorado.

Education

Fellowship Training

Children’s Hospital Colorado

Residency Training

George Washington University/Children’s National Medical Center and University of Colorado Medical Schools

Post-Doctoral Training

University of Colorado Cancer Center

Medical Schools

George Washington University School of Medicine and Health Sciences

Undergraduate Schools

BA, Carleton College

Awards & Recognitions

New Inventor of the Year 2007, University of Colorado

MD

• Division Head, Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation; Meryl Suzanne Weiss Distinguished Professor in Hematology, Oncology and Stem Cell Transplantation; Professor of Pediatrics, Northwestern University Feinberg School of Medicine
• Director, Center for Clinical Trials Research; Co-director, Falk Brain Tumor Center, Stanley Manne Children’s Research Institute

Education and Certification

MD: Loyola University/Stritch School of Medicine (1985)
Internship: University of Chicago Hospitals, Pediatrics (1986)
Residency: Univ. of Chicago Hospital, Pediatrics (1988)
Fellowship: Univ. of Chicago Hospital, Pediatrics Hematology-Oncology (1991)
Board Certification: Pediatric Hematology-Oncology

B.S., RPh, RAC, CIP CCRC, CCRP

• Director, Clinical Research and Early Product Development Center for Cell and Gene Therapy (CAGT) Baylor College of Medicine
• Assistant Professor Department of Pediatrics Section of Hematology-Oncology Baylor College of Medicine

Mrs. Bambi Grilley has worked in the area of Clinical Research for over 25 years. She has experience as an Investigational Drug Pharmacist, IRB administrator, IRB member, Regulatory Affairs professional, and in the conduct of clinical trials. She has always worked in the area of oncology and, in addition to that, has worked with cell and gene therapy protocols for over 15 years.

Mrs Grilley provides in-depth regulatory guidance to investigators developing projects involving translational products and assists in the regulatory submissions in support of these projects. She teaches about regulatory affairs and clinical research extensively both within BCM and internationally.

She has overseen the regulatory submissions for over 1,600 clinical research studies, almost half of which are therapeutic. She has assisted in the submission of over 75 investigator initiated INDs with over 110 studies conducted under them.  She has prepared and implemented over 100 Standard Operating Procedures for clinical research and has established Quality Assurance and Quality Control programs for the protocols being conducted under her purview. She has developed Data Review Processes for internally initiated studies including the establishment of Data Safety Monitoring Boards (DSMBs) for a select group of studies.

She is currently the Director of Clinical Research and Early Product Development for the Center for Cell and Gene Therapy (CAGT).

Education

B.S., Pharmacy, the University of Texas, Austin, TX

Certifications

RAC (RAPS) Certification – 2008
CCRA (CCRP) Certification – 1998
CCRC Certification – 1999
CIP Certification – 2000

Selected Memberships

Selected Member (term starting January 2012), Council for Certification of IRB Professionals (CCIP)
Member, Public Responsibility in Medicine and Research (PRIM&R)
Member, Drug Information Association (DIA)
Member, Society of Clinical Research Associates (SOCRA)
Member, Association of Clinical Research Professionals (ACRP)

MD, FACS

• Orange County Plastic Surgeon

Dr. Gregory Evans is a surgeon best known for performing cancer reconstruction procedures, including free tissue transfer for breast, head, and neck. He also specializes in the full spectrum of plastic surgery, with a focus on cosmetic surgery, such as face, eyes, abdomen, breasts and body contouring.

This January 2014, Dr. Evans was selected as one of the top California plastic surgery doctors by Orange Coast Magazine, a popular Orange County periodical

Board Certifications 

Board-certified by the American Board of Surgery – General and American Board of Plastic Surgery

Memberships

American Society of Plastic Surgeons (ASPS)
Fellow, American College of Surgeons (FACS)

MD

• Pediatric Oncologist

I am a pediatric oncologist who specializes in the care of children, teenagers, and young adults with brain and eye tumors, including medulloblastoma (the most common malignant brain tumor in children) and retinoblastoma (a rare eye tumor in children). I also treat children and teenagers with melanoma, and children and adults with a rare white blood cell disorder called Langerhans cell histiocytosis.

In my clinical research, my colleagues and I are seeking to develop more-effective therapies with fewer and less-severe side effects. For example, we are exploring a new treatment regimen for patients with medulloblastoma that is intended to reduce side effects by limiting the amount of radiation given to areas of the brain without cancer.

I am also working to develop new treatments for retinoblastoma, a rare eye tumor that occurs in children. These include the use of intensive therapy for children whose retinoblastoma has metastasized (spread outside of the eye) and local chemotherapy for those with advanced cancer in the eye.

In addition to patient care and research, I am one of the lead attendings on the Faculty Fellow Team. The team works closely with young doctors training in this subspecialty to help them learn how best to identify the individual needs of patients and manage the care of children with malignancies.

Nationally, I am on the Children’s Oncology Group Retinoblastoma and Brain Tumor Committees, and I serve as the Principal Investigator for national clinical trials dealing with these tumors.

I find it very rewarding to work with patients and their families and to tailor and explain to them their treatment options, guiding them in complex decision-making or exploring various alternatives. Our goal is to cure the cancer while leaving the patient with as normal a life as possible.

Clinical Expertise

Brain Tumors; Retinoblastoma

Awards and Honors

New York Magazine Top Doctors (2005-2016)

Education

MD, Duke University

Residencies: Pediatrics – Duke University

Fellowships: 

Pediatric Infectious Disease – Duke University/Muhimbili Medical Center; Pediatric Hematology/Oncology – Memorial Sloan Kettering Cancer Center

Board Certifications

Pediatric Hematology-Oncology

MD

• Director, Pediatric Brain Tumor Clinical Trials Program
  Senior Physician
• Assistant Professor of Pediatrics, Harvard Medical School

Dr. Susan Chi is a pediatric hematologist-oncologist in Boston, Massachusetts and is affiliated with multiple hospitals in the area, including Boston Children’s Hospital and Dana-Farber Cancer Institute. She received her medical degree from Icahn School of Medicine at Mount Sinai and has been in practice for more than 20 years. Dr. Chi accepts several types of health insurance, listed below. She is one of 63 doctors at Boston Children’s Hospital and one of 72 at Dana-Farber Cancer Institute who specialize in Pediatric Hematology-Oncology.

Education & Medical Training

• Yale-New Haven Hospital
  Residency , Pediatrics
• Memorial Sloan-Kettering Cancer Center
  Fellowship , Pediatric Hematology/Oncology
• NYU School of Medicine
  Fellowship , Pediatric Neuro-Oncology
• Icahn School of Medicine at Mount Sinai
  Medical School
• Yale-New Haven Hospital
  Chief Residency , Pediatrics
• Princeton University
  Other Training

Certifications & Licensure

• American Board of Pediatrics
  Certified in Pediatric Hematology-Oncology
• MA State Medical License
  Active through 2017

M.D.

• Clinical Director Pediatric Oncology
• Professor of Oncology
• Professor of Pediatrics
• Director, Pediatric Neuro Oncology

Expertise:

Pediatric Brain Cancer, Pediatric Brain Tumors, Pediatric Neuro-Oncology, Pediatric Oncology, Pediatric Spinal Cord Tumors, Von Hippel-Lindau (VHL)

Research Interests: Small-molecule and biological regulatory mechanisms; Control of DNA replication and chromosome superstructure; Structural and catalytic mechanisms of nucleic-acid machines and assemblies

MD, MSc

• Associate Professor Department of Pediatrics Section of Hematology-Oncology Baylor College of Medicine

Dr. Nabil Ahmed received his M.D. and his Masters in Public Health at Cairo University in Cairo, Egypt. Dr. Ahmed is a board-certified member of the American Board of Pediatrics and is a board-certified specialist in pediatric Hematology Oncology.

His clinical interests include bone marrow transplantation and cell and gene therapy.

Dr. Nabil Ahmed is a member of the Center for Cell and Gene Therapy (CAGT) and Dr. Helen Heslop’s Research Laboratory. He is also a member of the Brain Tumor Program.

Education

M.D., Faculty of Medicine, Cairo University, Cairo, Egypt
M.P.H. and Fellowship, National Cancer Institute Cairo University, Cairo, Egypt
Fellowship, Baylor College of Medicine
Residency, Children’s Hospital of New Jersey
Residency, Mount Sinai School of Medicine
B.S., Kasr El-Aini School of Medicine, Cairo University, Cairo, Egypt

Former Positions

1996-1997  Rotating Intern, Cairo University
1997-2000 Fellow, Pediatric Branch, National Cancer Institute, Cairo University
1998-2000 Chief Fellow, Pediatric Branch, National Cancer Institute, Cairo University
2000 Instructor, Pediatric Branch, National Cancer Institute, Cairo University
2000-2001 Resident, Lincoln Hospital, Dept. of Pediatrics, Weill-Cornell Medical College
2001-2002 Resident, Children’s Hospital of NJ, Mount Sinai School of Medicine
2002-2003 Chief Resident, Children’s Hospital of NJ, Mount Sinai School of Medicine
2003-2005 Clinical Postdoctoral Fellow, Pediatric Hematology and Oncology. BCM
2005-2006 Chief Fellow, Pediatric Hematology and Oncology: BCM
2003-present Member, The Center for Cell and Gene Therapy, BCM
2006-present Assistant Professor (non-tenure), Department of Pediatrics, BCM
2006-present Research Member, The Dan L Duncan Cancer Center, BCM
2009-present Assistant Professor (tenure-track), Department of Pediatrics, BCM

Honors

1990-1992 Dean’s Honor List. Kasr El-Aini School of Medicine: Cairo University
1994, 1995 Dean’s Honor List. Faculty of Medicine, Cairo University
1996 Graduation Honor of Excellence. Faculty of Medicine, Cairo University
2000 Master’s Degree Honor of Excellence (Cairo University MPH Program). Cairo University
2004 American Society of Clinical Oncology Foundation Merit Award
2006 The Russell and Virginia McFarland Award. Baylor College of Medicine
2006 American Society of Clinical Oncology (ASCO) Foundation Merit Award
2006 The Brigid Leventhal Award for Pediatric Hematology Oncology Research, ASCO
2007 Clinical Faculty Teaching Award, BCM
2008 Noellenburg Prize, The International Society of Paediatric Oncology (SIOP)
2009 The American Society for Bone Marrow Transplantation Merit Award (Salsman)
2010 The American Society for Gene and Cell Therapy Merit Award (Grada)

Board Certifications

American Board of Pediatrics – Board Certified in Pediatrics
American Board of Pediatrics – Board Certified in Pediatric Hematology and Oncology
Egyptian Ministry of Health and Population

Selected Memberships

Member, American Society of Bone Marrow Transplantation (ASBMT)
Member, American Society of Clinical Oncology (ASCO)
Member, American Society of Pediatric Hematology and Oncology (ASPHO)
Member, American Society of Hematology (ASH)
Member, Egyptian Medical Syndicate

Clinical Interests

Bone Marrow Transplantation
Cell and Gene Therapy

Research Interests

Tumor Immunology
Cellular Therapy for Brain Tumors (Cellular Therapy for Medulloblastoma)
Cellular Therapy for Solid Tumors
Transplant Immunology

M.D.

• Professor Pediatric Oncology, NCI – Cairo University.
• CEO, Children’s Cancer Hospital Foundation 57357 Group – Egypt.
• General Manager, Hospital 57357 – Egypt.

Sherif Abouelnaga has been a specialist of pediatric oncology for 25 years and received his appointment of Professor Pediatric Hematology Oncology in 2005 through the Cairo University and the National Cancer Institute. Dr. Sherif has had extensive experience in pediatric oncology as well as broad experience in program development and has been the visionary and driving force of the Children’s Cancer Hospital Egypt 57357 the first in Egypt, Africa and the Middle East,

Dr. Sherif lead the change for upgrading standards of healthcare for pediatric oncology patients at the National Cancer Institute in Cairo and adopting the most current healthcare management techniques believing that management is a science whose techniques must be applied in the overburdened healthcare system existing in Egypt

His passion for improving the lives of Egyptian children with cancer has lead him into tackling many issues from the development of the first clinical pharmacies in Egypt, upgrading blood bank and donor programs, creating proper tools for statistical gathering, fundraising, marketing, training and continuing professional development for all disciplines and levels of staff, clinical research, to facility design and program implementation.

His most significant achievement is the state of the art Children’s Cancer Hospital Egypt 57357, which was opened in 2007 after 10 years of planning and construction. It is the largest children’s cancer hospital in the world and is completely free for all patients. Under his direction, the training and development and research departments have developed comprehensive programs and strategies to ensure the position of the CCHE as a leader in quality healthcare delivery. He is the acknowledged leader in developing an entirely new concept of fundraising in Egypt and is responsible for raising over 2 billion LE for his various healthcare projects in the last 25 years.

MD, MS

• Attending Physician; Hematology, Oncology and Blood and Marrow Transplantation
• Associate Professor of Pediatrics, USC Keck School of Medicine
• Director of BMT Fellowship Program

Dr. Abdel-Azim is currently a principal and a co-principal investigator on several investigator-initiated and multi-center studies. He has authored numerous peer-reviewed journal articles and book chapters. His lab research is mainly focused on acute leukemia and flow image analysis.

Clinical Interests

Dr. Abdel-Azim is an expert in blood and marrow transplantation, cellular and immunotherapy for a wide variety of cancers, bone marrow disorders, and genetic and non-malignant diseases. He also has special expertise in laboratory assessment for minimal residual disease in blood cancers and immune recovery after blood and marrow transplantation. His research interests include infections in immune compromised host, reduction of transplant-associated complications, treatment of graft vs host disease, and use of cell therapy for treatment of malignant and non-malignant diseases.

Education

Medical School: 

Cairo University School of Medicine, Cairo, Egypt MD; Cairo University School of Medicine, Cairo, Egypt MS

Internship: 

New York Medical College (Metropolitan Program), New York/Valhalla, NY

Residency: 

New York Medical College (Metropolitan Program), New York/Valhalla, NY

Fellowship: 

Hematology/Oncology: Children’s Hospital Los Angeles, Los Angeles, CA Blood and Marrow Transplantation: Children’s Hospital Los Angeles, Los Angeles, CA

Accomplishments

Certification:

Dr. Abdel-Azim is a board-certified physician in Hematology/Oncology and General

Practice.

Medical Memberships: 

ASBMT, ASH, ASPHO, COG

Medical Awards: 

Top doctors, Pasadena Magazine, Southern California Super Doctors

MD, PhD (Chair)

• Director, Pediatric Medical Neuro-Oncology, Dana-Farber/Boston Children’s Medical School

Dr. Kieran received his PhD in 1983 from the University of Alberta, Edmonton, Canada, and his MD in 1986 from the University of Calgary. He completed postgraduate training in molecular biology at the Pasteur Institute in Paris.  After a pediatric residency in Montreal at McGill University, he received postdoctoral education at Boston Children’s Hospital (BCH). In 1998, he became director of Pediatric Medical Neuro-Oncology at Dana-Farber/Boston Children’s. In addition to his role in the treatment of patients with brain tumors and the development of novel agents for the treatment of recurrent tumors, he continues to focus his laboratory efforts on angiogenesis agents from work he started in the laboratory of the late Dr. Judah Folkman.

He is a recipient of many awards including the Nick Palmer Lecture Award from the International Symposium on Pediatric Neuro-Oncology and presents lectures both at home and abroad, most recently at the Children’s Cancer Institute of Egypt and the Beijing Children’s Hospital.

Dr. Kieran is a member of the Society for Neuro-Oncology, the Society of Pediatric Research, and the American Society for Clinical Oncology. He is the editor in chief of Clinical Oncology in Adolescent and Young Adult and serves on the Editorial Board of Neuro-Oncology. Dr. Kieran is an ad hoc reviewer for many journals including the New England Journal of Medicine, Pediatric Blood and Cancer, Cancer Research, and the Journal of Pediatric Hematology/Oncology.

Education

Medical School

University of Calgary Faculty of Medicine, 1986

Calgary, CANADA

Montreal Children’s Hospital

Pediatrics – McGill University, 1989-1992

Quebec, CANADA

Fellowship

Pediatric Hematology/Oncology – Boston Children’s Hospital/Dana-Farber Cancer Institute, 1992-1995

Boston, MA